nodes	percent_of_prediction	percent_of_DWPC	metapath
Calcipotriol—MPO—superior mesenteric artery—pancreatic cancer	0.386	0.855	CbGeAlD
Calcipotriol—CYP24A1—digestive system—pancreatic cancer	0.0256	0.0568	CbGeAlD
Calcipotriol—Skin hyperpigmentation—Erlotinib—pancreatic cancer	0.0174	0.0466	CcSEcCtD
Calcipotriol—MPO—IL23-mediated signaling events—IL24—pancreatic cancer	0.0174	0.0997	CbGpPWpGaD
Calcipotriol—Folliculitis—Erlotinib—pancreatic cancer	0.0165	0.0441	CcSEcCtD
Calcipotriol—Skin irritation—Fluorouracil—pancreatic cancer	0.0164	0.0438	CcSEcCtD
Calcipotriol—Application site pain—Fluorouracil—pancreatic cancer	0.0161	0.043	CcSEcCtD
Calcipotriol—Skin hyperpigmentation—Sunitinib—pancreatic cancer	0.0151	0.0403	CcSEcCtD
Calcipotriol—Hypercalcaemia—Tamoxifen—pancreatic cancer	0.0151	0.0403	CcSEcCtD
Calcipotriol—VDR—digestive system—pancreatic cancer	0.0141	0.0313	CbGeAlD
Calcipotriol—MPO—pancreas—pancreatic cancer	0.0139	0.0309	CbGeAlD
Calcipotriol—Hypercalcaemia—Sunitinib—pancreatic cancer	0.0129	0.0345	CcSEcCtD
Calcipotriol—VDR—Nuclear Receptors—NR5A2—pancreatic cancer	0.0125	0.0715	CbGpPWpGaD
Calcipotriol—Skin hyperpigmentation—Fluorouracil—pancreatic cancer	0.0119	0.0318	CcSEcCtD
Calcipotriol—MPO—digestive system—pancreatic cancer	0.0119	0.0264	CbGeAlD
Calcipotriol—Skin exfoliation—Tamoxifen—pancreatic cancer	0.01	0.0267	CcSEcCtD
Calcipotriol—Skin exfoliation—Erlotinib—pancreatic cancer	0.00991	0.0265	CcSEcCtD
Calcipotriol—VDR—Nuclear Receptor transcription pathway—NR5A2—pancreatic cancer	0.00985	0.0565	CbGpPWpGaD
Calcipotriol—Tingling sensation—Fluorouracil—pancreatic cancer	0.00882	0.0235	CcSEcCtD
Calcipotriol—Stinging—Fluorouracil—pancreatic cancer	0.00875	0.0234	CcSEcCtD
Calcipotriol—Skin hyperpigmentation—Docetaxel—pancreatic cancer	0.0086	0.023	CcSEcCtD
Calcipotriol—Skin exfoliation—Sunitinib—pancreatic cancer	0.00858	0.0229	CcSEcCtD
Calcipotriol—Dry skin—Erlotinib—pancreatic cancer	0.0069	0.0184	CcSEcCtD
Calcipotriol—Skin exfoliation—Gemcitabine—pancreatic cancer	0.00688	0.0184	CcSEcCtD
Calcipotriol—Dry skin—Sunitinib—pancreatic cancer	0.00598	0.016	CcSEcCtD
Calcipotriol—Skin hyperpigmentation—Epirubicin—pancreatic cancer	0.0058	0.0155	CcSEcCtD
Calcipotriol—Folliculitis—Epirubicin—pancreatic cancer	0.00549	0.0147	CcSEcCtD
Calcipotriol—Skin hyperpigmentation—Doxorubicin—pancreatic cancer	0.00537	0.0143	CcSEcCtD
Calcipotriol—VDR—Validated transcriptional targets of TAp63 isoforms—SHH—pancreatic cancer	0.00516	0.0296	CbGpPWpGaD
Calcipotriol—Folliculitis—Doxorubicin—pancreatic cancer	0.00508	0.0136	CcSEcCtD
Calcipotriol—Hypercalcaemia—Epirubicin—pancreatic cancer	0.00497	0.0133	CcSEcCtD
Calcipotriol—Skin exfoliation—Docetaxel—pancreatic cancer	0.00488	0.013	CcSEcCtD
Calcipotriol—Dry skin—Fluorouracil—pancreatic cancer	0.00472	0.0126	CcSEcCtD
Calcipotriol—Hypercalcaemia—Doxorubicin—pancreatic cancer	0.0046	0.0123	CcSEcCtD
Calcipotriol—Erythema—Tamoxifen—pancreatic cancer	0.00459	0.0122	CcSEcCtD
Calcipotriol—Erythema—Erlotinib—pancreatic cancer	0.00454	0.0121	CcSEcCtD
Calcipotriol—VDR—Validated transcriptional targets of TAp63 isoforms—GADD45A—pancreatic cancer	0.00438	0.0251	CbGpPWpGaD
Calcipotriol—VDR—Validated transcriptional targets of TAp63 isoforms—JAG1—pancreatic cancer	0.00438	0.0251	CbGpPWpGaD
Calcipotriol—Stinging—Epirubicin—pancreatic cancer	0.00426	0.0114	CcSEcCtD
Calcipotriol—VDR—RXR and RAR heterodimerization with other nuclear receptor—PPARG—pancreatic cancer	0.0041	0.0235	CbGpPWpGaD
Calcipotriol—CYP24A1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—pancreatic cancer	0.00395	0.0226	CbGpPWpGaD
Calcipotriol—Stinging—Doxorubicin—pancreatic cancer	0.00394	0.0105	CcSEcCtD
Calcipotriol—Erythema—Sunitinib—pancreatic cancer	0.00393	0.0105	CcSEcCtD
Calcipotriol—VDR—Validated transcriptional targets of deltaNp63 isoforms—BRCA2—pancreatic cancer	0.00379	0.0217	CbGpPWpGaD
Calcipotriol—MPO—Vitamin B12 Metabolism—SOD2—pancreatic cancer	0.00365	0.021	CbGpPWpGaD
Calcipotriol—MPO—IL23-mediated signaling events—NFKBIA—pancreatic cancer	0.00361	0.0207	CbGpPWpGaD
Calcipotriol—VDR—Validated transcriptional targets of deltaNp63 isoforms—HES1—pancreatic cancer	0.00358	0.0205	CbGpPWpGaD
Calcipotriol—VDR—Direct p53 effectors—NDRG1—pancreatic cancer	0.00354	0.0203	CbGpPWpGaD
Calcipotriol—Dry skin—Docetaxel—pancreatic cancer	0.0034	0.00909	CcSEcCtD
Calcipotriol—Paraesthesia—Tamoxifen—pancreatic cancer	0.00336	0.00897	CcSEcCtD
Calcipotriol—VDR—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—pancreatic cancer	0.00331	0.019	CbGpPWpGaD
Calcipotriol—Skin exfoliation—Epirubicin—pancreatic cancer	0.00329	0.0088	CcSEcCtD
Calcipotriol—Pain—Tamoxifen—pancreatic cancer	0.0032	0.00854	CcSEcCtD
Calcipotriol—Pain—Erlotinib—pancreatic cancer	0.00317	0.00845	CcSEcCtD
Calcipotriol—Erythema—Gemcitabine—pancreatic cancer	0.00315	0.00841	CcSEcCtD
Calcipotriol—Erythema—Fluorouracil—pancreatic cancer	0.0031	0.00827	CcSEcCtD
Calcipotriol—Skin exfoliation—Doxorubicin—pancreatic cancer	0.00305	0.00814	CcSEcCtD
Calcipotriol—VDR—Nuclear Receptors—PPARG—pancreatic cancer	0.00302	0.0173	CbGpPWpGaD
Calcipotriol—VDR—Direct p53 effectors—TNFRSF10B—pancreatic cancer	0.00301	0.0173	CbGpPWpGaD
Calcipotriol—MPO—Vitamin B12 Metabolism—APOE—pancreatic cancer	0.003	0.0172	CbGpPWpGaD
Calcipotriol—MPO—Folate Metabolism—SOD2—pancreatic cancer	0.00297	0.017	CbGpPWpGaD
Calcipotriol—Paraesthesia—Sunitinib—pancreatic cancer	0.00288	0.00768	CcSEcCtD
Calcipotriol—Hypersensitivity—Tamoxifen—pancreatic cancer	0.00276	0.00736	CcSEcCtD
Calcipotriol—Pain—Sunitinib—pancreatic cancer	0.00274	0.00732	CcSEcCtD
Calcipotriol—VDR—Validated transcriptional targets of deltaNp63 isoforms—NOTCH1—pancreatic cancer	0.0027	0.0155	CbGpPWpGaD
Calcipotriol—Pruritus—Tamoxifen—pancreatic cancer	0.00265	0.00707	CcSEcCtD
Calcipotriol—Pruritus—Erlotinib—pancreatic cancer	0.00262	0.00699	CcSEcCtD
Calcipotriol—VDR—Direct p53 effectors—TGFA—pancreatic cancer	0.00256	0.0147	CbGpPWpGaD
Calcipotriol—MPO—C-MYB transcription factor network—HES1—pancreatic cancer	0.00246	0.0141	CbGpPWpGaD
Calcipotriol—VDR—Nuclear Receptor transcription pathway—PPARG—pancreatic cancer	0.00239	0.0137	CbGpPWpGaD
Calcipotriol—VDR—Regulation of nuclear SMAD2/3 signaling—SMAD4—pancreatic cancer	0.00237	0.0136	CbGpPWpGaD
Calcipotriol—Paraesthesia—Irinotecan—pancreatic cancer	0.00237	0.00633	CcSEcCtD
Calcipotriol—MPO—Selenium Micronutrient Network—SOD2—pancreatic cancer	0.00236	0.0135	CbGpPWpGaD
Calcipotriol—Hypersensitivity—Sunitinib—pancreatic cancer	0.00236	0.00631	CcSEcCtD
Calcipotriol—Rash—Tamoxifen—pancreatic cancer	0.00236	0.0063	CcSEcCtD
Calcipotriol—Dermatitis—Tamoxifen—pancreatic cancer	0.00236	0.00629	CcSEcCtD
Calcipotriol—Rash—Erlotinib—pancreatic cancer	0.00233	0.00623	CcSEcCtD
Calcipotriol—Dermatitis—Erlotinib—pancreatic cancer	0.00233	0.00623	CcSEcCtD
Calcipotriol—VDR—RXR and RAR heterodimerization with other nuclear receptor—TGFB1—pancreatic cancer	0.00233	0.0134	CbGpPWpGaD
Calcipotriol—Paraesthesia—Gemcitabine—pancreatic cancer	0.00231	0.00617	CcSEcCtD
Calcipotriol—Dry skin—Epirubicin—pancreatic cancer	0.0023	0.00613	CcSEcCtD
Calcipotriol—VDR—Direct p53 effectors—HSPA1B—pancreatic cancer	0.00228	0.0131	CbGpPWpGaD
Calcipotriol—Paraesthesia—Fluorouracil—pancreatic cancer	0.00227	0.00606	CcSEcCtD
Calcipotriol—Pruritus—Sunitinib—pancreatic cancer	0.00227	0.00605	CcSEcCtD
Calcipotriol—Pain—Irinotecan—pancreatic cancer	0.00226	0.00603	CcSEcCtD
Calcipotriol—Erythema—Docetaxel—pancreatic cancer	0.00224	0.00597	CcSEcCtD
Calcipotriol—Pain—Gemcitabine—pancreatic cancer	0.0022	0.00587	CcSEcCtD
Calcipotriol—VDR—RXR and RAR heterodimerization with other nuclear receptor—TNF—pancreatic cancer	0.00218	0.0125	CbGpPWpGaD
Calcipotriol—Pain—Fluorouracil—pancreatic cancer	0.00216	0.00577	CcSEcCtD
Calcipotriol—VDR—Validated transcriptional targets of deltaNp63 isoforms—CDKN2A—pancreatic cancer	0.00215	0.0123	CbGpPWpGaD
Calcipotriol—Dry skin—Doxorubicin—pancreatic cancer	0.00212	0.00567	CcSEcCtD
Calcipotriol—MPO—IL23-mediated signaling events—STAT3—pancreatic cancer	0.00207	0.0119	CbGpPWpGaD
Calcipotriol—VDR—Direct p53 effectors—GADD45A—pancreatic cancer	0.00204	0.0117	CbGpPWpGaD
Calcipotriol—Rash—Sunitinib—pancreatic cancer	0.00202	0.0054	CcSEcCtD
Calcipotriol—Dermatitis—Sunitinib—pancreatic cancer	0.00202	0.00539	CcSEcCtD
Calcipotriol—Hypersensitivity—Irinotecan—pancreatic cancer	0.00195	0.00519	CcSEcCtD
Calcipotriol—VDR—Direct p53 effectors—HSPA1A—pancreatic cancer	0.00193	0.011	CbGpPWpGaD
Calcipotriol—VDR—Validated transcriptional targets of TAp63 isoforms—CDKN2A—pancreatic cancer	0.00192	0.011	CbGpPWpGaD
Calcipotriol—Hypersensitivity—Fluorouracil—pancreatic cancer	0.00186	0.00497	CcSEcCtD
Calcipotriol—Pruritus—Gemcitabine—pancreatic cancer	0.00182	0.00486	CcSEcCtD
Calcipotriol—MPO—IL23-mediated signaling events—TNF—pancreatic cancer	0.00179	0.0103	CbGpPWpGaD
Calcipotriol—Pruritus—Fluorouracil—pancreatic cancer	0.00179	0.00478	CcSEcCtD
Calcipotriol—VDR—Generic Transcription Pathway—NR5A2—pancreatic cancer	0.0017	0.00976	CbGpPWpGaD
Calcipotriol—Rash—Irinotecan—pancreatic cancer	0.00166	0.00444	CcSEcCtD
Calcipotriol—Dermatitis—Irinotecan—pancreatic cancer	0.00166	0.00444	CcSEcCtD
Calcipotriol—Paraesthesia—Docetaxel—pancreatic cancer	0.00164	0.00438	CcSEcCtD
Calcipotriol—MPO—IL23-mediated signaling events—PIK3CA—pancreatic cancer	0.00163	0.00936	CbGpPWpGaD
Calcipotriol—Rash—Gemcitabine—pancreatic cancer	0.00162	0.00433	CcSEcCtD
Calcipotriol—Dermatitis—Gemcitabine—pancreatic cancer	0.00162	0.00433	CcSEcCtD
Calcipotriol—Rash—Fluorouracil—pancreatic cancer	0.00159	0.00426	CcSEcCtD
Calcipotriol—Dermatitis—Fluorouracil—pancreatic cancer	0.00159	0.00425	CcSEcCtD
Calcipotriol—Pain—Docetaxel—pancreatic cancer	0.00156	0.00417	CcSEcCtD
Calcipotriol—Erythema—Epirubicin—pancreatic cancer	0.00151	0.00403	CcSEcCtD
Calcipotriol—MPO—C-MYB transcription factor network—CDKN2A—pancreatic cancer	0.00147	0.00844	CbGpPWpGaD
Calcipotriol—VDR—Retinoic acid receptors-mediated signaling—AKT1—pancreatic cancer	0.00144	0.00828	CbGpPWpGaD
Calcipotriol—Erythema—Doxorubicin—pancreatic cancer	0.0014	0.00373	CcSEcCtD
Calcipotriol—MPO—Vitamin B12 Metabolism—TNF—pancreatic cancer	0.00139	0.00794	CbGpPWpGaD
Calcipotriol—MPO—C-MYB transcription factor network—PTGS2—pancreatic cancer	0.00138	0.00789	CbGpPWpGaD
Calcipotriol—Hypersensitivity—Docetaxel—pancreatic cancer	0.00134	0.00359	CcSEcCtD
Calcipotriol—MPO—Selenium Micronutrient Network—PTGS2—pancreatic cancer	0.00133	0.00761	CbGpPWpGaD
Calcipotriol—Pruritus—Docetaxel—pancreatic cancer	0.00129	0.00345	CcSEcCtD
Calcipotriol—VDR—Direct p53 effectors—BCL2L1—pancreatic cancer	0.00126	0.00721	CbGpPWpGaD
Calcipotriol—VDR—Direct p53 effectors—TSC2—pancreatic cancer	0.00125	0.00717	CbGpPWpGaD
Calcipotriol—MPO—C-MYB transcription factor network—CCND1—pancreatic cancer	0.00124	0.00713	CbGpPWpGaD
Calcipotriol—VDR—Direct p53 effectors—MET—pancreatic cancer	0.00117	0.00672	CbGpPWpGaD
Calcipotriol—Rash—Docetaxel—pancreatic cancer	0.00115	0.00307	CcSEcCtD
Calcipotriol—Dermatitis—Docetaxel—pancreatic cancer	0.00115	0.00307	CcSEcCtD
Calcipotriol—MPO—Folate Metabolism—TNF—pancreatic cancer	0.00113	0.00646	CbGpPWpGaD
Calcipotriol—Paraesthesia—Epirubicin—pancreatic cancer	0.00111	0.00295	CcSEcCtD
Calcipotriol—MPO—C-MYB transcription factor network—NRAS—pancreatic cancer	0.00107	0.00614	CbGpPWpGaD
Calcipotriol—Pain—Epirubicin—pancreatic cancer	0.00105	0.00281	CcSEcCtD
Calcipotriol—Paraesthesia—Doxorubicin—pancreatic cancer	0.00102	0.00273	CcSEcCtD
Calcipotriol—VDR—Direct p53 effectors—RB1—pancreatic cancer	0.00102	0.00585	CbGpPWpGaD
Calcipotriol—MPO—C-MYB transcription factor network—MYC—pancreatic cancer	0.000998	0.00572	CbGpPWpGaD
Calcipotriol—MPO—Folate Metabolism—TP53—pancreatic cancer	0.000994	0.0057	CbGpPWpGaD
Calcipotriol—VDR—Direct p53 effectors—MMP2—pancreatic cancer	0.000978	0.00561	CbGpPWpGaD
Calcipotriol—VDR—Gene Expression—CHD3—pancreatic cancer	0.000978	0.00561	CbGpPWpGaD
Calcipotriol—VDR—Generic Transcription Pathway—MEN1—pancreatic cancer	0.000978	0.0056	CbGpPWpGaD
Calcipotriol—Pain—Doxorubicin—pancreatic cancer	0.000974	0.0026	CcSEcCtD
Calcipotriol—VDR—Regulation of nuclear SMAD2/3 signaling—MYC—pancreatic cancer	0.000941	0.0054	CbGpPWpGaD
Calcipotriol—VDR—Generic Transcription Pathway—NOTCH4—pancreatic cancer	0.000927	0.00531	CbGpPWpGaD
Calcipotriol—MPO—C-MYB transcription factor network—KRAS—pancreatic cancer	0.000922	0.00529	CbGpPWpGaD
Calcipotriol—Hypersensitivity—Epirubicin—pancreatic cancer	0.000907	0.00242	CcSEcCtD
Calcipotriol—MPO—Selenium Micronutrient Network—TNF—pancreatic cancer	0.000896	0.00513	CbGpPWpGaD
Calcipotriol—Pruritus—Epirubicin—pancreatic cancer	0.000871	0.00233	CcSEcCtD
Calcipotriol—Hypersensitivity—Doxorubicin—pancreatic cancer	0.000839	0.00224	CcSEcCtD
Calcipotriol—VDR—Gene Expression—NR5A2—pancreatic cancer	0.000819	0.0047	CbGpPWpGaD
Calcipotriol—Pruritus—Doxorubicin—pancreatic cancer	0.000806	0.00215	CcSEcCtD
Calcipotriol—VDR—Generic Transcription Pathway—NOTCH3—pancreatic cancer	0.000788	0.00452	CbGpPWpGaD
Calcipotriol—MPO—C-MYB transcription factor network—HRAS—pancreatic cancer	0.000784	0.00449	CbGpPWpGaD
Calcipotriol—Rash—Epirubicin—pancreatic cancer	0.000776	0.00207	CcSEcCtD
Calcipotriol—Dermatitis—Epirubicin—pancreatic cancer	0.000775	0.00207	CcSEcCtD
Calcipotriol—CYP24A1—Metabolism—PRSS1—pancreatic cancer	0.00076	0.00436	CbGpPWpGaD
Calcipotriol—VDR—Direct p53 effectors—PTEN—pancreatic cancer	0.000731	0.00419	CbGpPWpGaD
Calcipotriol—Rash—Doxorubicin—pancreatic cancer	0.000718	0.00192	CcSEcCtD
Calcipotriol—Dermatitis—Doxorubicin—pancreatic cancer	0.000718	0.00192	CcSEcCtD
Calcipotriol—CYP24A1—Metabolism—ARG2—pancreatic cancer	0.000659	0.00378	CbGpPWpGaD
Calcipotriol—VDR—Regulation of nuclear SMAD2/3 signaling—AKT1—pancreatic cancer	0.000653	0.00374	CbGpPWpGaD
Calcipotriol—VDR—Direct p53 effectors—EGFR—pancreatic cancer	0.000594	0.00341	CbGpPWpGaD
Calcipotriol—VDR—Generic Transcription Pathway—SMAD4—pancreatic cancer	0.000594	0.0034	CbGpPWpGaD
Calcipotriol—CYP24A1—Metabolism—TYMP—pancreatic cancer	0.000576	0.0033	CbGpPWpGaD
Calcipotriol—VDR—Direct p53 effectors—TP53—pancreatic cancer	0.000499	0.00286	CbGpPWpGaD
Calcipotriol—CYP24A1—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	0.000476	0.00273	CbGpPWpGaD
Calcipotriol—VDR—Gene Expression—MEN1—pancreatic cancer	0.000471	0.0027	CbGpPWpGaD
Calcipotriol—CYP24A1—Metabolism—GLP1R—pancreatic cancer	0.000465	0.00266	CbGpPWpGaD
Calcipotriol—CYP24A1—Metabolism—DPYD—pancreatic cancer	0.000457	0.00262	CbGpPWpGaD
Calcipotriol—VDR—Gene Expression—NOTCH4—pancreatic cancer	0.000446	0.00256	CbGpPWpGaD
Calcipotriol—VDR—Generic Transcription Pathway—NOTCH1—pancreatic cancer	0.000437	0.00251	CbGpPWpGaD
Calcipotriol—CYP24A1—Metabolism—SLC2A2—pancreatic cancer	0.000434	0.00249	CbGpPWpGaD
Calcipotriol—CYP24A1—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	0.000429	0.00246	CbGpPWpGaD
Calcipotriol—VDR—Gene Expression—HSPA1B—pancreatic cancer	0.000426	0.00244	CbGpPWpGaD
Calcipotriol—CYP24A1—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	0.000414	0.00237	CbGpPWpGaD
Calcipotriol—VDR—Generic Transcription Pathway—PPARG—pancreatic cancer	0.000413	0.00237	CbGpPWpGaD
Calcipotriol—VDR—Gene Expression—EZH2—pancreatic cancer	0.000388	0.00222	CbGpPWpGaD
Calcipotriol—VDR—Gene Expression—NOTCH3—pancreatic cancer	0.000379	0.00217	CbGpPWpGaD
Calcipotriol—CYP24A1—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	0.000377	0.00216	CbGpPWpGaD
Calcipotriol—VDR—Gene Expression—HSPA1A—pancreatic cancer	0.000359	0.00206	CbGpPWpGaD
Calcipotriol—CYP24A1—Metabolism—CD44—pancreatic cancer	0.000336	0.00193	CbGpPWpGaD
Calcipotriol—CYP24A1—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	0.000329	0.00189	CbGpPWpGaD
Calcipotriol—CYP24A1—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	0.000326	0.00187	CbGpPWpGaD
Calcipotriol—CYP24A1—Metabolism—GCG—pancreatic cancer	0.000322	0.00185	CbGpPWpGaD
Calcipotriol—CYP24A1—Metabolism—STK11—pancreatic cancer	0.000303	0.00174	CbGpPWpGaD
Calcipotriol—VDR—Gene Expression—SMAD4—pancreatic cancer	0.000286	0.00164	CbGpPWpGaD
Calcipotriol—CYP24A1—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	0.000284	0.00163	CbGpPWpGaD
Calcipotriol—CYP24A1—Metabolism—TYMS—pancreatic cancer	0.00026	0.00149	CbGpPWpGaD
Calcipotriol—VDR—Generic Transcription Pathway—MYC—pancreatic cancer	0.000235	0.00135	CbGpPWpGaD
Calcipotriol—CYP24A1—Metabolism—APOE—pancreatic cancer	0.000212	0.00121	CbGpPWpGaD
Calcipotriol—VDR—Gene Expression—NOTCH1—pancreatic cancer	0.000211	0.00121	CbGpPWpGaD
Calcipotriol—CYP24A1—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	0.0002	0.00115	CbGpPWpGaD
Calcipotriol—VDR—Gene Expression—PPARG—pancreatic cancer	0.000199	0.00114	CbGpPWpGaD
Calcipotriol—CYP24A1—Metabolism—PIK3CG—pancreatic cancer	0.000191	0.0011	CbGpPWpGaD
Calcipotriol—CYP24A1—Metabolism—PPARG—pancreatic cancer	0.000184	0.00106	CbGpPWpGaD
Calcipotriol—CYP24A1—Metabolism—PIK3CD—pancreatic cancer	0.000168	0.000963	CbGpPWpGaD
Calcipotriol—CYP24A1—Metabolism—PIK3CB—pancreatic cancer	0.000146	0.00084	CbGpPWpGaD
Calcipotriol—CYP24A1—Metabolism—PTGS2—pancreatic cancer	0.000145	0.000832	CbGpPWpGaD
Calcipotriol—CYP24A1—Metabolism—PTEN—pancreatic cancer	0.000127	0.000725	CbGpPWpGaD
Calcipotriol—VDR—Gene Expression—MYC—pancreatic cancer	0.000113	0.00065	CbGpPWpGaD
Calcipotriol—CYP24A1—Metabolism—PIK3CA—pancreatic cancer	8.93e-05	0.000512	CbGpPWpGaD
Calcipotriol—VDR—Gene Expression—AKT1—pancreatic cancer	7.86e-05	0.000451	CbGpPWpGaD
Calcipotriol—CYP24A1—Metabolism—AKT1—pancreatic cancer	7.29e-05	0.000418	CbGpPWpGaD
